Evidence map›Paper›PMID 42827536›Full record

ArticleFrontiers in pharmacology2026

Total flavonoids of

Yang Yang, Yingxue Yang, Jingyu Ouyang, Zhikui Cheng, Zhuojian Lu, Xinyong Lv, Jiacheng Wei, Xin Zhao, Yun Feng, Yang Yue and 3 more

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yang YangHubei Bio-Pharmaceutical Industrial Technological Institute Inc., Humanwell Healthcare (Group) Co, Ltd., Wuhan, Hubei, China.
Yingxue YangHubei Bio-Pharmaceutical Industrial Technological Institute Inc., Humanwell Healthcare (Group) Co, Ltd., Wuhan, Hubei, China.
Jingyu OuyangHubei Bio-Pharmaceutical Industrial Technological Institute Inc., Humanwell Healthcare (Group) Co, Ltd., Wuhan, Hubei, China.
Zhikui ChengHubei Bio-Pharmaceutical Industrial Technological Institute Inc., Humanwell Healthcare (Group) Co, Ltd., Wuhan, Hubei, China.
Zhuojian LuHubei Bio-Pharmaceutical Industrial Technological Institute Inc., Humanwell Healthcare (Group) Co, Ltd., Wuhan, Hubei, China.
Xinyong LvHubei Bio-Pharmaceutical Industrial Technological Institute Inc., Humanwell Healthcare (Group) Co, Ltd., Wuhan, Hubei, China.
Jiacheng WeiHubei Bio-Pharmaceutical Industrial Technological Institute Inc., Humanwell Healthcare (Group) Co, Ltd., Wuhan, Hubei, China.
Xin ZhaoHubei Bio-Pharmaceutical Industrial Technological Institute Inc., Humanwell Healthcare (Group) Co, Ltd., Wuhan, Hubei, China.
Yun FengHubei Bio-Pharmaceutical Industrial Technological Institute Inc., Humanwell Healthcare (Group) Co, Ltd., Wuhan, Hubei, China.
Yang YueHubei Bio-Pharmaceutical Industrial Technological Institute Inc., Humanwell Healthcare (Group) Co, Ltd., Wuhan, Hubei, China.
Wentao DuHubei Bio-Pharmaceutical Industrial Technological Institute Inc., Humanwell Healthcare (Group) Co, Ltd., Wuhan, Hubei, China.
Lifei LiuHubei Bio-Pharmaceutical Industrial Technological Institute Inc., Humanwell Healthcare (Group) Co, Ltd., Wuhan, Hubei, China.
Xuejun ZhangHubei Bio-Pharmaceutical Industrial Technological Institute Inc., Humanwell Healthcare (Group) Co, Ltd., Wuhan, Hubei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: The inhibitory effects of TFDS on calcium oxalate monohydrate (COM) crystallization were quantified Results: Conclusion: TFDS exerts a potent anti-lithogenic effect by targeting multiple stages of the crystallization process-inhibiting crystal nucleation and growth, promoting dissolution, and preventing cellular adhesion and endocytosis,and suppressing associated inflammation. These findings provide a scientific cognition for the traditional use of

Indexed as

calcium oxalate crystallizationinflammationnephrolithiasistotal flavonoids of Desmodium styracifoliumurolithiasis

Identifiers

PMID42827536
PMCPMC13630956

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.